| Literature DB >> 10959773 |
Abstract
In the years to come, pharmacogenomics will make an impact on the development of new drugs. Numerous publications have shown that gene polymorphism can influence drug toxicity and/or efficacy. In order to improve current applications of pharmacogenomics, some technical limitations regarding marker generation, genotyping and biostatistical analysis are being overcome.Entities:
Mesh：
Year: 2000 PMID： 10959773 DOI： 10.1016/s1367-5931(00)00101-0
Source DB: PubMed Journal: Curr Opin Chem Biol ISSN： 1367-5931 Impact factor: 8.822